Merck (NYSE:MRK) said the FDA has granted Breakthrough Therapy designation for its antibody drug conjugate sacituzumab tirumotecan, also known as sac-TMT, for the treatment of a certain type of ...

In 1997, after receiving his doctorate in biochemistry from the UC-Berkeley and a postdoctoral degree from Harvard Medical School, Dr. Li went to work for Merck Research Laboratories. At Merck, he led ...